Merck scores a win in $1.4B insurance fight over devastating cyberattack
Merck scores a win in $1.4B insurance fight over devastating [...]
UCB buys rare disease drugmaker Zogenix for up to $1.9B, bolstering its epilepsy position
UCB buys rare disease drugmaker Zogenix for up to $1.9B, [...]
FDA extends decision dates on bluebird bio’s gene therapy drugs beti-cel and eli-cel by 3 months
FDA extends decision dates on bluebird bio’s gene therapy drugs [...]
Inside the Catalent FDA citation said to trigger Novo Nordisk’s Wegovy supply hiccup
Inside the Catalent FDA citation said to trigger Novo Nordisk’s [...]
Hikma shells out $45.75M to buy bankrupt Teligent’s Canadian assets
Hikma shells out $45.75M to buy bankrupt Teligent’s Canadian assets [...]
Shkreli hit with $64.6M verdict, lifetime pharma ban in antitrust case
Shkreli hit with $64.6M verdict, lifetime pharma ban in antitrust [...]
Pfizer’s Cibinqo snags FDA approval to challenge Sanofi and Regeneron’s Dupixent in eczema
Pfizer’s Cibinqo snags FDA approval to challenge Sanofi and Regeneron’s [...]
Novo Nordisk comes out clean in $1.8B investor lawsuit alleging insulin misdirection
Novo Nordisk comes out clean in $1.8B investor lawsuit alleging [...]
Emergent BioSolutions founder El-Hibri bids adieu after CDMO’s turbulent 2021
Emergent BioSolutions founder El-Hibri bids adieu after CDMO’s turbulent 2021 [...]
Califf advances in FDA chief nomination process but committee vote indicates he’s no slam-dunk choice
Califf advances in FDA chief nomination process but committee vote [...]